# Pulmonology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elizabeth Barrett Browning (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI026-SYN
- Date: 2026-03-23
- Fictional facility: St. Posthumous Health Center
- Fictional author: Ravindra Ellesmere-Park, MD
- Calendar frame: modern shifted

- Requested by: Clementine Haverford-Asante, MD

## Reason for consultation

Chronic productive cough for several years with occasional streaks of blood in the sputum and breathlessness on stairs, in a thin 39-year-old poet who had a chest illness with blood in the sputum about eight years ago and has taken prescribed oral morphine for many years. Please help exclude tuberculosis and nontuberculous mycobacterial disease, establish the diagnosis (bronchiectasis is suspected), plan its care, and advise on morphine and her lungs. **S**

## History

Ms. Barrett Browning, a 39-year-old poet, is seen at the request of Dr. Haverford-Asante one week after her first visit. She describes a daily cough with three to four tablespoons of yellow sputum for several years, worse each winter, with about two chest infections a year that settle slowly, and streaks of blood every few weeks, never more than a thread; the last was three days ago. She becomes breathless on a flight of stairs. About eight years ago she coughed up blood during an illness that left her largely housebound since. She had a serious illness at about fifteen. She has never smoked and has no known exposure to tuberculosis. She has no sinus symptoms, heartburn, or joint problems. She takes morphine solution 10 mg twice daily, prescribed for years for cough, sleeplessness and palpitations; she has wondered whether it is bad for her chest. She would like to be able to go out in good weather and to keep writing. **S**

## Examination

| System | Finding |
|---|---|
| General | Thin, alert, speaking in full sentences; weight 41.6 kg; oxygen saturation 96% on room air |
| Respiratory | Coarse crackles at the left base and left mid-zone that shift with coughing; no wheeze or bronchial breathing |
| Hands | No clubbing |
| Ears, nose, mouth, and throat | No nasal polyps; sinuses not tender |
| Cardiovascular | Regular rhythm, 92 per minute; no murmur; no ankle edema |
| Neurological | Not drowsy; pupils normal size |

BP 100/64 mmHg; pulse 92 bpm; respirations 18/min; temperature 36.8 °C; oxygen saturation 96% on room air; weight 41.6 kg; BMI 16.9 kg/m². All vital signs are synthetic.

## Data reviewed

Dr. Haverford-Asante's intake note and results. Three sputum samples: acid-fast smears negative and nucleic acid amplification negative for Mycobacterium tuberculosis; mycobacterial cultures pending; routine culture Haemophilus influenzae, beta-lactamase negative. Interferon-gamma release assay negative; HIV test negative. Blood count normal with eosinophils 0.21 x10^3/uL; CRP 8.4 mg/L. Today: CT of the chest with contrast and thin-section reconstructions shows cylindrical bronchiectasis of the left lower lobe and lingula with bronchial wall thickening and mucus plugging, some tree-in-bud change in the left lower lobe, and no cavity, nodule, mass, lymph node enlargement or anomalous systemic artery; the upper lobes are clear. Spirometry after bronchodilator: FEV1 2.02 L (74% predicted), FVC 2.93 L, FEV1/FVC 0.69, with no significant bronchodilator response. IgG 1180, IgA 236 and IgM 142 mg/dL; total IgE 38 IU/mL; Aspergillus-specific IgE 0.08 kU/L. FEV1 after bronchodilator: 2.02 L (low); FEV1 percent predicted after bronchodilator: 74% (low); FVC after bronchodilator: 2.93 L; FEV1/FVC after bronchodilator: 0.69 (low); IgG: 1180 mg/dL; IgA: 236 mg/dL; IgM: 142 mg/dL; Total IgE: 38 [IU]/mL; Aspergillus fumigatus specific IgE: 0.08 k[IU]/L. All results are synthetic.

## Assessment

1. **Bronchiectasis, left lower lobe and lingula** (J47.9). The CT confirms cylindrical bronchiectasis confined to the left lower lobe and lingula, which explains the daily sputum, the crackles, the mild obstruction and the streaks of blood from inflamed bronchial walls. The pattern and her history point to damage from a severe infection years ago. Normal immunoglobulins and a negative Aspergillus IgE exclude antibody deficiency and allergic bronchopulmonary aspergillosis; nothing in her history suggests cystic fibrosis, a ciliary disorder or connective tissue disease, so those tests are not needed now. Haemophilus influenzae is the usual organism. Bronchiectasis Severity Index 3: mild. **S**
2. **Tuberculosis, nontuberculous mycobacteria, and other lesions** (J47.9). Three negative smears, a negative NAAT and a negative IGRA make tuberculosis very unlikely, and she no longer needs to mask; the cultures will be final in six to eight weeks. Nontuberculous mycobacteria, which favour thin women with bronchiectasis, cannot be excluded until the cultures are final; the tree-in-bud change is more likely from retained mucus, and the diagnosis would need two positive sputum cultures with compatible imaging. The CT shows no sequestration, mass or other lesion, so bronchoscopy is not needed. **S**
3. **Morphine and the lungs** (Z79.891). At 20 mg a day she shows no sedation or slowed breathing and her oxygen saturation is normal, so the dose is not dangerous to her lungs in itself. But morphine suppresses cough, and in bronchiectasis the cough is how she clears sputum; once airway clearance is established, a slow reduction would be reasonable if she wishes it. There is no pulmonary reason to change the dose urgently, and it should never be stopped abruptly. Codeine and other cough suppressants should be avoided, and naloxone kept at home. **S**
4. **Blood in the sputum**. Streaking only, from bronchiectasis, with no lesion needing treatment. Bronchial artery embolization is for large or repeated bleeding and is not needed. **S**

## Recommendations

1. Stop masking: tuberculosis is very unlikely; follow the mycobacterial cultures to their final result at six to eight weeks, and repeat a mycobacterial culture yearly or with any unexplained decline.
2. Airway clearance twice daily with the active cycle of breathing technique and an oscillating positive expiratory pressure device, taught by the respiratory physiotherapist this week, more often during exacerbations.
3. A home exercise program to build strength and stamina, with weight-bearing exercise.
4. Influenza vaccine yearly and a pneumococcal vaccine, with COVID-19 vaccination as recommended.
5. A written exacerbation plan: for three days or more of worse cough, more or darker sputum and more breathlessness, send a sputum sample and start amoxicillin 500 mg three times daily for 14 days (chosen by her Haemophilus influenzae culture), and call the clinic.
6. No long-term macrolide or inhaled antibiotic while she has fewer than three exacerbations a year; no inhaled corticosteroid without asthma.
7. Sputum culture at each review and with every exacerbation; spirometry, Bronchiectasis Severity Index and a mycobacterial culture yearly.
8. Morphine: no change for pulmonary reasons now; a slow reduction of about 10 percent at a time is reasonable if she chooses it once airway clearance is established; no codeine or other cough suppressants; naloxone at home.
9. Call 911 or go to the emergency department for more than a few teaspoons of blood, blood with breathlessness, chest pain or dizziness; no bronchial artery treatment is needed now.

## Strengths and supports

- Supports: her writing, her correspondents, her sisters' company, and a strong sense of humour; financially independent through a legacy **S**

## Communication

Discussed with Dr. Haverford-Asante the same day, who continues the opioid review and the grief care. The CT was shown to Ms. Barrett Browning, who asked whether she had consumption and was relieved by the answer; she asked whether she could go out in good weather, and was told that fresh air and exercise will help her lungs. **S**

## Follow-up

Pulmonology review if the mycobacterial cultures are positive, exacerbations reach three a year, blood returns in more than streaks, or the FEV1 falls; otherwise Dr. Haverford-Asante will follow the yearly checks. **S**

## Guideline basis

- British Thoracic Society Guideline for Bronchiectasis in Adults (2019), British Thoracic Society (Thorax 2019;74 Suppl 1:1-69)
- European Respiratory Society guidelines for the management of adult bronchiectasis (2017), European Respiratory Society (Eur Respir J 2017;50(3):1700629)
- Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children (2017), ATS, IDSA and CDC (Clin Infect Dis 2017;64(2):111-115)
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline (2020), ATS, ERS, ESCMID and IDSA (Clin Infect Dis 2020;71(4):e1-e36)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recomm Rep 2022;71(3):1-95)
